St. Luke's Roosevelt Hospital Center — New York, New York

St. Luke's Roosevelt Hospital Center is a clinical research site located in New York, New York, United States 10025.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

St. Luke's Roosevelt Hospital Center has participated in 23 clinical trials.

Therapeutic areas: Opioid Dependency, End Stage Renal Failure on Dialysis, Hyperplasia.

Sponsors: Titan Pharmaceuticals, Angiotech Pharmaceuticals, LEO Pharma.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Luke's Roosevelt Hospital Center?

St. Luke's Roosevelt Hospital Center has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Luke's Roosevelt Hospital Center conducted?

St. Luke's Roosevelt Hospital Center has 23 clinical trials on record. Their work covers Opioid Dependency, End Stage Renal Failure on Dialysis, Hyperplasia.

Is St. Luke's Roosevelt Hospital Center accredited by Crixeo Health?

Yes — St. Luke's Roosevelt Hospital Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about St. Luke's Roosevelt Hospital Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.